M&R 5.1 Effects of electical signals - ligand gated ion channels Flashcards

1
Q

Name 3 types of voltage-gated ion channels located in an axon membrane

A

Voltage gated Na+ & K+ channels (along the axonal membrane)
Voltage-gated Ca2+ channels (concentrated at the nerve terminal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the general effects of depolarisation on voltage-gated Ca2+ channels and the consequences

A

Depolarisation opens VGCCs
Ca2+ enters the nerve terminal
Increased [Ca2+]i triggers the release of neurotransmitters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the intracellular and extracellular concentrations of Ca2+ in an axon?
What is ECa ?

A
Intracellular = 1x10-7M 
Extracellular = 1x10-3M

ECa = +122mV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

is the structure of VGCCs most similar to that of VGNCs or VGKCs?

A

VG Na+ channels

Both have a single alpha subunit with 4 ‘quarters’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Where are L-type Ca2+ channels found?

A

Muscle (skeletal, smooth, cardiac) , neurones and lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which group are specific blockers of L-type Ca2+ channels?

A

Dihydropiridines (e.g. nifedipine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does phosphorylation of Ca2+ channels do?

A

Makes the channel open more at any given voltage - therefore increases permeability to Ca2+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In the NMJ, where are the Ca2+ channels located? Why?

A

Close to vesicle release sites
So an increase in [Ca2+]i following an AP reaching the terminal can activate proteins associated with vesicles, to promote exocytosis of ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the process (and proteins involved) in transmitter release at the NMJ

A

Ca2+ enters via VGCCs
Ca2+ binds to synaptotagmin, which brings the vesicle close to the membrane
SNARE complex makes a fusion pore between vesicle and membrane
ACh released via fusion pore into synaptic cleft

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In the NMJ, what receptor does ACh bind to on the post-junctional membrane? What type of receptor is this?

A

Nicotinic ACh receptor (nAChR)

= a ligand-gated ion channel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do nAChRs work?

A

Each nAChR has 2 binding sites for ACh (on the 2 alpha subunits)
When both have bound ACh, a conformational change causes the ion channel to open

The channel is a non-specific cation channel - allows Na+ and K+ through [Na+ enters, K+ leaves]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

If NMJ nAChRs let both Na+ and K+ through, then why does their activation result in depolarisation?

A

The RMP of skeletal muscles is ~85-90mV
Therefore RMP is close to Ek, so there is little driving force for K+ to leave
RMP is far from ENa, so there is a big driving force for Na+ to enter
Therefore Na+ entry will overcome K+ exit = net inward flow of positively charged ions = depolarisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the depolarisation produced by the nAChR after ACh binding called?
What does it do?

A

An end-plate potential (EPP)

It in turn raises the muscle above threshold so that VGNCs are activated and an AP is produced in the muscle membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the ‘reversal potential’ of an ion channel?

A

The point at which there is no net movement across the membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is the amplitude of an EPP related to calcium concentration? What does this prove?

A

The EPP amplitude decreases as Ca2+ concentration is decreased

Proves that Ca2+ release is a necessary step for transmitter release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is synaptic transmission terminated in the NMJ?

A

Degradation of ACh by acetylcholinesterase (AChE)

17
Q

Name a competitive blocker of nAChRs

A

d-Tubocurarine

18
Q

Name a depolarising blocker of nAChRs

A

succinylcholine

19
Q

How does d-tubocurarine block nAChRs?

A

Competitive block - it sits in ACh’s binding sites which prevents ACh from binding.
It doesn’t cause the conformational change, so the channel remains closed and no EPP is produced.

20
Q

How does succinylcholine block nAChRs?

A

Depolarising block:
(normally brief depolarisation at the post-junctional membrane activates adjacent Na+ channels by local spread of charge, causing a muscle AP)

Succinylcholine causes a prolonged depolarisation. This causes adjacent Na+ channels to become inactivated, so they can no longer be activated to cause a muscle AP

21
Q

Can competitive block by tubocurarine be overcome?

A

Yes - block can be overcome if lots of ACh around - displaces curare

22
Q

Can depolarising block by succinylcholine be overcome?

A

No
Even if some ACh came along and managed to bind with some free receptors & depolarise further, this would not be able to trigger the AP because of inactivated Na+ channels

23
Q

What is a miniature end-plate potential (MEPP)?

A

A small depolarisation , due to the spontaneous release of a vesicle resulting in its package of ACh being released

Always similar size (~1mV) because vesicles are similar sizes
don’t reach threshold or activate AP

24
Q

What is Myasthenia Gravis?

A

An autoimmune disease where patients suffer profound muscle weakness, which increases with exercise

25
Q

Which receptors are affected in Myasthenia gravis? How?

A

Antibodies are directed at the nAChRs on the post-synaptic membrane of skeletal muscle
This leads to loss of functional nAChR by complement-mediated lysis and receptor degradation

26
Q

How are EPPs affected in Myasthenia gravis? Why?

A

EPPs are reduced in amplitude
Because although the same amount of ACh is released per vesicle, the response is smaller because nAChRs have been damaged

27
Q

What class of drug can be used to treat both Myasthenia gravis and d-tubocurarine toxicity? Why?

A

Acetylcholinesterase inhibitors

Because in both conditions the availability of functioning nAChR receptors is reduced. The AChE inhibitor blocks ACh degradation, therefore raising the amount in the NMJ. The extra ACh which collects can then correct for the lack of functioning nAChRs by activating the remaining normal receptors at a higher rate.

28
Q

__________ - __________ ________ is the mechanism by which an AP in a muscle fibre leads to contraction of the fibre

A

Excitation-contraction coupling